Lyme disease testing relies on a two-step blood test that detects antibodies your immune system produces against the bacteria. But the right test depends on timing: if you have the characteristic bull’s-eye rash, no blood test is needed at all. A doctor can diagnose Lyme disease on sight. For everything else, there’s a specific sequence of blood work, and understanding how it works helps you know what to expect and how to interpret your results.
When No Blood Test Is Needed
The most recognizable sign of Lyme disease is an expanding red skin lesion called erythema migrans, the so-called bull’s-eye rash. It starts as a small red spot at the tick bite site and grows over days to weeks, often developing partial clearing in the center. To count as diagnostic, the lesion needs to reach at least 5 centimeters in diameter (about 2 inches). If a healthcare provider sees this rash on someone who lives in or traveled to a Lyme-endemic area, current guidelines from the Infectious Diseases Society of America recommend clinical diagnosis and immediate treatment, no lab work required.
This matters because blood tests can actually miss early Lyme disease. Your body needs time to build antibodies against the bacteria, and during the first four to six weeks after infection, standard tests can come back falsely negative. So if you have the rash, waiting for blood work could delay treatment unnecessarily.
The Standard Two-Tier Blood Test
When there’s no rash or the clinical picture isn’t clear, doctors order a two-step blood test. The first step is a screening blood test (an immunoassay) that looks for antibodies to the Lyme bacteria. If this first test comes back negative, no further testing is done. If it comes back positive or borderline, the lab runs a second, more specific test to confirm.
In the traditional version of this process, the confirmatory test is called a Western blot, which identifies antibodies to specific proteins from the Lyme bacteria. Two versions are run: one for IgM antibodies (the kind your body produces early in an infection) and one for IgG antibodies (which develop later and persist longer). The IgM blot is considered positive if it detects antibodies to at least 2 out of 3 specific bacterial proteins. The IgG blot requires antibodies to at least 5 out of 10 specific proteins to count as positive. That high bar for the IgG test is intentional, designed to reduce false positives.
One important detail: IgM results are only meaningful within the first 30 days of symptoms. After that window, a positive IgM is unreliable because it can stay elevated long after the infection has resolved, or it can be a false positive. If you’ve had symptoms for more than a month, only the IgG result matters.
The Modified Two-Tier Test
A newer approach, called modified two-tiered testing (MTTT), replaces the Western blot with a second, different immunoassay. Instead of waiting for a lab to run a blot, the confirmatory step uses another antibody-detecting blood test, which can return results faster. The FDA has cleared specific pairs of tests to be used together for this purpose. The logic is the same: two tests in sequence, where the second confirms the first. Your doctor chooses which version to order based on what’s available at their lab.
Why Timing Changes Everything
The biggest limitation of all Lyme blood tests is the antibody window. Because these tests detect your immune response rather than the bacteria itself, they can miss infections in the first four to six weeks. Someone bitten by a tick last week who already feels flu-like symptoms could test completely negative and still have Lyme disease.
If your doctor suspects early Lyme despite a negative test, they may treat based on symptoms and exposure history, then retest a few weeks later. Antibody levels rise over time, so a test that was negative at week two might be positive at week six. Late-stage Lyme disease, with joint pain, nerve involvement, or heart problems, is much easier to detect because the immune response has had months to build. Nearly all patients with late-stage disease test positive.
PCR Testing for Specific Situations
PCR tests detect the actual DNA of the Lyme bacteria rather than antibodies. This sounds like it should be more reliable, but in practice, PCR plays a limited supporting role. The bacteria don’t circulate freely in the blood in large numbers, so PCR is not a good general screening tool.
Where PCR does help is in specific tissues. It can detect bacterial DNA in skin biopsies when a rash doesn’t look like classic erythema migrans. It’s also useful for testing joint fluid when Lyme arthritis is suspected. In spinal fluid, detection is possible but less reliable. A negative PCR result doesn’t rule out Lyme disease because bacterial DNA may simply not be present in the sample at detectable levels. For this reason, PCR is always used alongside standard antibody testing, never as a standalone.
Tests That Don’t Hold Up
Some specialty labs market T-cell based tests, like the ELISpot assay, which measures immune cells that react to Lyme bacteria. The idea is appealing: instead of measuring antibodies, measure the cellular immune response directly. But research has found these tests cannot distinguish between an active infection and a past, cured one. A 2018 study in the Journal of Clinical Microbiology showed the ELISpot assay performed only slightly better than a coin flip at identifying active Lyme neuroborreliosis, with reactivity showing up equally in people with current disease and those who had been successfully treated years earlier. These tests are not recommended by major medical guidelines.
Testing for Co-Infections
The same ticks that carry Lyme bacteria can transmit other pathogens at the same time. If you develop a high fever after a tick bite, your doctor may order a broader tick-borne disease panel alongside Lyme testing. Unlike Lyme disease, infections like anaplasmosis, ehrlichiosis, and babesiosis are best detected through PCR testing of blood rather than antibody tests, especially in the acute phase. These co-infections can cause symptoms that overlap with Lyme, including fever, fatigue, and muscle aches, so identifying them matters for getting the right treatment.
What to Expect at Your Appointment
If you’re concerned about Lyme disease, your doctor will consider three things: your symptoms, whether you’ve been in a tick-endemic area, and the timing of any known tick bite. A single standard blood draw is all that’s needed for the two-tier test. Results typically take a few days, though the modified two-tier approach can sometimes be faster.
If your first test is negative but symptoms persist and exposure was likely, a follow-up test in two to four weeks is reasonable. Antibody levels can also remain elevated for months or even years after successful treatment, so a positive test in someone who has already been treated doesn’t necessarily mean the infection is still active. Your doctor will interpret the results in context with how you’re actually feeling, not as a standalone verdict.